Advertisement
UK markets close in 5 hours 45 minutes

  • FTSE 100

    8,089.36
    +48.98 (+0.61%)
     

  • FTSE 250

    19,728.53
    +9.16 (+0.05%)
     

  • AIM

    755.15
    +0.46 (+0.06%)
     

  • GBP/EUR

    1.1670
    +0.0025 (+0.21%)
     

  • GBP/USD

    1.2522
    +0.0060 (+0.48%)
     

  • Bitcoin GBP

    51,038.56
    -1,957.52 (-3.69%)
     

  • CMC Crypto 200

    1,363.77
    -18.81 (-1.36%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.72
    -0.09 (-0.11%)
     

  • GOLD FUTURES

    2,337.80
    -0.60 (-0.03%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,984.98
    -103.72 (-0.57%)
     

  • CAC 40

    8,050.95
    -40.91 (-0.51%)
     
Property:

How to sell your home

Top tips from property investors

Company News for Jun 29, 2021

Zacks Equity Research
·1-min read

  • Shares of Intellia Therapeutics, Inc. NTLA surged 50.2% after the company reported positive clinical data for its CRISPR therapy.

  • Anavex Life Sciences Corp.’s AVXL shares jumped 16.6% after the company reported that its ANAVEX2-73 has improved MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson's.

  • Shares of MannKind Corporation MNKD rose 11.6% after the company reported that Medicare patients will be able to use its Afrezza and continuous glucose monitoring devices starting in July.

  • Kymera Therapeutics, Inc.’s KYMR shares jumped 6.3% after the company reported that its KT-474 has achieved and exceeded Phase 1 target degradation of 85% within the SAD portion of the Phase 1 trial.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MannKind Corporation (MNKD) : Free Stock Analysis Report
 
Anavex Life Sciences Corp. (AVXL) : Free Stock Analysis Report
 
Intellia Therapeutics, Inc. (NTLA) : Free Stock Analysis Report
 
Kymera Therapeutics, Inc. (KYMR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research